Showing results (171-180 of 420) with videos related to

Sort By:
Pageof 42
RSC Advances|March 25, 2024
Recent advances in DDAH1 inhibitor design and discovery: insights from structure-activity relationships and X-ray crystal structuresAnthony J Doman, Michael V Perkins, Sara Tommasi, et al.
European Journal of Clinical Investigation|July 6, 2024
The association between bilirubin concentrations and inflammatory bowel disease: Insights from a systematic review and meta-analysisStefano Zoroddu, Biagio Di Lorenzo, Panagiotis Paliogiannis, et al.
Frontiers in Public Health|September 7, 2021
Cholesterol and Triglyceride Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-RegressionAngelo Zinellu, Panagiotis Paliogiannis, Alessandro G Fois, et al.
Frontiers in Cardiovascular Medicine|December 11, 2025
Associations of novel blood-derived markers of inflammation with blood pressure, arterial stiffness and heart rate in young adultsRichard J Woodman, Angelo Zinellu, Trevor A Mori, et al.
Clinical Medicine (London, England)|February 5, 2015
Drug therapies in older adults (part 1)Omar Mukhtar, Stephen H D Jackson
International Journal of Molecular Sciences|September 20, 2019
The Second Life of Methylarginines as Cardiovascular TargetsNatalia Jarzebska, Arduino A Mangoni, Jens Martens-Lobenhoffer, et al.
British Journal of Clinical Pharmacology|August 18, 2012
The Hypertension in the Very Elderly Trial - latest dataOmar Mukhtar, Stephen H D Jackson
British Journal of Clinical Pharmacology|July 11, 2012
Risk: benefit of treating high blood pressure in older adultsOmar Mukhtar, Stephen H D Jackson
Pharmacogenomics and Personalized Medicine|December 7, 2018
Genetic polymorphism of the methotrexate transporter ABCG2, blood pressure and markers of arterial function in patients with rheumatoid arthritis: repeated cross-sectional studyLeena R Baghdadi, Richard J Woodman, E Michael Shanahan, et al.
British Journal of Clinical Pharmacology|November 28, 2017
Evaluation of modafinil as a perpetrator of metabolic drug-drug interactions using a model informed cocktail reaction phenotyping trial protocolAngela Rowland, Madelé van Dyk, David Warncken, et al.
Pageof 42